SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-24-002740
Filing Date
2024-04-26
Accepted
2024-04-26 16:30:38
Documents
3
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K xenetic_10ka1-123123.htm 10-K/A 269692
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_ex3103.htm EX-31.3 4529
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_ex3104.htm EX-31.4 4321
  Complete submission text file 0001683168-24-002740.txt   279769
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37937 | Film No.: 24884365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)